193 related articles for article (PubMed ID: 18393801)
1. Epsilon-secretase: reduction of amyloid precursor protein epsilon-site cleavage in Alzheimer's disease.
Kametani F
Curr Alzheimer Res; 2008 Apr; 5(2):165-71. PubMed ID: 18393801
[TBL] [Abstract][Full Text] [Related]
2. Abeta 11-40/42 production without gamma-secretase epsilon-site cleavage.
Kume H; Kametani F
Biochem Biophys Res Commun; 2006 Nov; 349(4):1356-60. PubMed ID: 16979587
[TBL] [Abstract][Full Text] [Related]
3. Intracellular domain generation of amyloid precursor protein by epsilon-cleavage depends on C-terminal fragment by alpha-secretase cleavage.
Kume H; Maruyama K; Kametani F
Int J Mol Med; 2004 Jan; 13(1):121-5. PubMed ID: 14654982
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
5. Lysine 624 of the amyloid precursor protein (APP) is a critical determinant of amyloid β peptide length: support for a sequential model of γ-secretase intramembrane proteolysis and regulation by the amyloid β precursor protein (APP) juxtamembrane region.
Kukar TL; Ladd TB; Robertson P; Pintchovski SA; Moore B; Bann MA; Ren Z; Jansen-West K; Malphrus K; Eggert S; Maruyama H; Cottrell BA; Das P; Basi GS; Koo EH; Golde TE
J Biol Chem; 2011 Nov; 286(46):39804-12. PubMed ID: 21868378
[TBL] [Abstract][Full Text] [Related]
6. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.
Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A
J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942
[TBL] [Abstract][Full Text] [Related]
7. The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase.
Nunan J; Shearman MS; Checler F; Cappai R; Evin G; Beyreuther K; Masters CL; Small DH
Eur J Biochem; 2001 Oct; 268(20):5329-36. PubMed ID: 11606195
[TBL] [Abstract][Full Text] [Related]
8. The physical approximation of APP and BACE-1: A key event in alzheimer's disease pathogenesis.
Sun J; Roy S
Dev Neurobiol; 2018 Mar; 78(3):340-347. PubMed ID: 29106038
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
10. gamma-Secretase can cleave amyloid precursor protein fragments independent of alpha- and beta-secretase pre-cutting.
Kume H; Sekijima Y; Maruyama K; Kametani F
Int J Mol Med; 2003 Jul; 12(1):57-60. PubMed ID: 12792809
[TBL] [Abstract][Full Text] [Related]
11. The role of TMP21 in trafficking and amyloid-β precursor protein (APP) processing in Alzheimer's disease.
Bromley-Brits K; Song W
Curr Alzheimer Res; 2012 May; 9(4):411-24. PubMed ID: 22299712
[TBL] [Abstract][Full Text] [Related]
12. Gamma-secretase catalyzes sequential cleavages of the AbetaPP transmembrane domain.
Xu X
J Alzheimers Dis; 2009; 16(2):211-24. PubMed ID: 19221413
[TBL] [Abstract][Full Text] [Related]
13. Transmembrane Substrate Determinants for γ-Secretase Processing of APP CTFβ.
Fernandez MA; Biette KM; Dolios G; Seth D; Wang R; Wolfe MS
Biochemistry; 2016 Oct; 55(40):5675-5688. PubMed ID: 27649271
[TBL] [Abstract][Full Text] [Related]
14. Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer's disease development: An up-to-date review.
Yuksel M; Tacal O
Eur J Pharmacol; 2019 Aug; 856():172415. PubMed ID: 31132354
[TBL] [Abstract][Full Text] [Related]
15. APP processing in Alzheimer's disease.
Zhang YW; Thompson R; Zhang H; Xu H
Mol Brain; 2011 Jan; 4():3. PubMed ID: 21214928
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms that synergistically regulate η-secretase processing of APP and Aη-α protein levels: relevance to pathogenesis and treatment of Alzheimer's disease.
Ward J; Wang H; Saunders AJ; Tanzi RE; Zhang C
Discov Med; 2017 Feb; 23(125):121-128. PubMed ID: 28371615
[TBL] [Abstract][Full Text] [Related]
17. beta-Secretase cleavage of the amyloid precursor protein mediates neuronal apoptosis caused by familial Alzheimer's disease mutations.
McPhie DL; Golde T; Eckman CB; Yager D; Brant JB; Neve RL
Brain Res Mol Brain Res; 2001 Dec; 97(1):103-13. PubMed ID: 11744168
[TBL] [Abstract][Full Text] [Related]
18. Successive cleavage of β-amyloid precursor protein by γ-secretase.
Funamoto S; Tagami S; Okochi M; Morishima-Kawashima M
Semin Cell Dev Biol; 2020 Sep; 105():64-74. PubMed ID: 32354467
[TBL] [Abstract][Full Text] [Related]
19. Ubiquilin-1 modulates γ-secretase-mediated ε-site cleavage in neuronal cells.
Viswanathan J; Haapasalo A; Kurkinen KM; Natunen T; Mäkinen P; Bertram L; Soininen H; Tanzi RE; Hiltunen M
Biochemistry; 2013 Jun; 52(22):3899-912. PubMed ID: 23663107
[TBL] [Abstract][Full Text] [Related]
20. A Novel Cell-based β-secretase Enzymatic Assay for Alzheimer's Disease.
De Araujo Herculano B; Wang Z; Song W
Curr Alzheimer Res; 2019; 16(2):128-134. PubMed ID: 30543168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
